Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for acute COPD exacerbations with hospitalisation (BACE)
2013-004420-11Phase 3Completed
- Sponsor
- KU Leuven
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of azithromycin in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by KU Leuven. Primary endpoint: time to treatment failure. Started Feb 2014; status: completed.
02
Drugs
azithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2013-004420-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004420-11.